15/10/2026
EQS-News: Fresenius SE & Co. KGaA
/ Key word(s): Personnel
Supervisory Board appoints Dr. Marc-Alexander Mahl to the Fresenius Management Board and extends Sara Hennicken’s contract (news with additional features)
15.10.2026 /...
01/10/2026
EQS-News: Fresenius SE & Co. KGaA
/ Key word(s): Strategic Company Decision
Fresenius acquires remaining 45% of mAbxience for up to €750 million, taking full ownership of its biosimilars platform (news with additional...
20/08/2026
EQS-News: Fresenius SE & Co. KGaA
/ Key word(s): Investment
Fresenius raises approximately €300 million through sale of 7.8 million Fresenius Medical Care shares (news with additional features)
20.08.2026 / 18:35 CET/CEST
The...
10/08/2026
EQS-News: Fresenius SE & Co. KGaA
/ Key word(s): Rating
Fitch Ratings upgrades outlook for Fresenius SE from stable to positive
10.08.2026 / 14:30 CET/CEST
The issuer is solely responsible for the content of this...
06/08/2026
EQS-News: Fresenius SE & Co. KGaA
/ Key word(s): Miscellaneous/AGM/EGM
Fresenius transitions to registered shares – automatic conversion for shareholders
06.08.2026 / 13:00 CET/CEST
The issuer is solely responsible for the...
04/08/2026
EQS-News: Fresenius SE & Co. KGaA
/ Key word(s): Quarter Results
#FutureFresenius: Excellent Q2 performance demonstrates structural step-up – Guidance raised
04.08.2026 / 22:03 CET/CEST
The issuer is solely responsible for...
04/08/2026
EQS-Ad-hoc: Fresenius SE & Co. KGaA / Key word(s): Forecast / Full year
Fresenius SE & Co. KGaA: Fresenius raises its earnings guidance for fiscal year 2026 due to strong operational business performance
04-Aug-2026 / 22:01...
23/07/2026
EQS-News: Fresenius SE & Co. KGaA
/ Key word(s): Financing/Strategic Company Decision
Fresenius establishes venture fund of more than €200 million to drive healthcare innovation
23.07.2026 / 10:00 CET/CEST
The issuer is...